Trials / Conditions / Unresectable Esophageal Cancer
Unresectable Esophageal Cancer
4 registered clinical trials studyying Unresectable Esophageal Cancer — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People Wit NCT06251973 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Suspended | Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbet NCT05400122 | David Wald | Phase 1 |
| Unknown | Efficacy and Safety of Neo-CRT Followed Surgery Compared With Definitive CRT in Patients With Initial Unresect NCT04137679 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Completed | Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer NCT04005170 | Mian XI | Phase 2 |